Methadone Take-Home Policies and Associated Mortality: Permitting versus Non-Permitting States.
Subst Use
; 18: 29768357241272379, 2024.
Article
en En
| MEDLINE
| ID: mdl-39161774
ABSTRACT
To mitigate COVID-19 exposure risks in methadone clinics, the Substance Abuse and Mental Health Services Administration (SAMHSA) issued a temporary modification of regulations in March 2020 to permit, with state concurrence, extended take-home methadone doses. The modification allowed for up to 28 days of take-home methadone for stable patients and 14 days for those less stable. Using both interrupted time series and difference-in-differences methods, this study examined the association between the policy change and fatal methadone overdoses, comparing states that permitted the expansion of take-home doses with states that did not. The findings suggest the pandemic emergency take-home policy did not increase methadone-involved mortality.
Texto completo:
1
Base de datos:
MEDLINE
Idioma:
En
Revista:
Subst Use
Año:
2024
Tipo del documento:
Article